Divi's Gears Up For A Biosimilars Play, Move Comes At The Back Of Demand From Existing Clients
This article was originally published in PharmAsia News
Executive Summary
HYDERABAD, India - Years of relationship with large multinational companies has prompted Divi's Labs - one of India's largest contract manufacturers for pharmaceutical raw materials or bulk drugs - to explore a presence in the biosimilars manufacturing space